These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
341 related items for PubMed ID: 15967914
1. Prediction of survival for patients with bullous pemphigoid: a prospective study. Joly P, Benichou J, Lok C, Hellot MF, Saiag P, Tancrede-Bohin E, Sassolas B, Labeille B, Doutre MS, Gorin I, Pauwels C, Chosidow O, Caux F, Estève E, Dutronc Y, Sigal M, Prost C, Maillard H, Guillaume JC, Roujeau JC. Arch Dermatol; 2005 Jun; 141(6):691-8. PubMed ID: 15967914 [Abstract] [Full Text] [Related]
2. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study. Bernard P, Reguiai Z, Tancrède-Bohin E, Cordel N, Plantin P, Pauwels C, Vaillant L, Grange F, Richard-Lallemand MA, Sassolas B, Roujeau JC, Lok C, Picard-Dahan C, Chosidow O, Vitry F, Joly P. Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497 [Abstract] [Full Text] [Related]
3. [One year follow-up of patients with bullous pemphigoid]. Doffoel-Hantz V, Sparsa A, Marin B, Durox H, Bonnetblanc JM, Bédane C. Ann Dermatol Venereol; 2009 May; 136(5):407-11. PubMed ID: 19442795 [Abstract] [Full Text] [Related]
4. Neurological disorders in patients with bullous pemphigoid. Cordel N, Chosidow O, Hellot MF, Delaporte E, Lok C, Vaillant L, Bernard P, D'Incan M, Roujeau JC, Joly P, French Study Group of Bullous Diseases. Dermatology; 2007 May; 215(3):187-91. PubMed ID: 17823513 [Abstract] [Full Text] [Related]
5. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid. Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, Vaillant L, D'Incan M, Plantin P, Bedane C, Young P, Bernard P, Bullous Diseases French Study Group. N Engl J Med; 2002 Jan 31; 346(5):321-7. PubMed ID: 11821508 [Abstract] [Full Text] [Related]
6. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial. Mahaffey KW, Yang Q, Pieper KS, Antman EM, White HD, Goodman SG, Cohen M, Kleiman NS, Langer A, Aylward PE, Col JJ, Reist C, Ferguson JJ, Califf RM, SYNERGY Trial Investigators. J Gen Intern Med; 2008 Mar 31; 23(3):310-6. PubMed ID: 18196350 [Abstract] [Full Text] [Related]
7. [Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid]. Zimmermann R, Faure M, Claudy A. Ann Dermatol Venereol; 1999 Jan 31; 126(1):13-6. PubMed ID: 10095883 [Abstract] [Full Text] [Related]
8. Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients. Bernard P, Bedane C, Bonnetblanc JM. Br J Dermatol; 1997 May 31; 136(5):694-8. PubMed ID: 9205501 [Abstract] [Full Text] [Related]
9. [Survival prognosis in pemphigoid. A cohort analysis of 78 patients]. Bernard P, Enginger V, Venot J, Bedane C, Bonnetblanc JM. Ann Dermatol Venereol; 1995 May 31; 122(11-12):751-7. PubMed ID: 8729818 [Abstract] [Full Text] [Related]
10. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database. Weiss ES, Nwakanma LU, Patel ND, Yuh DD. J Heart Lung Transplant; 2008 Feb 31; 27(2):184-91. PubMed ID: 18267225 [Abstract] [Full Text] [Related]
13. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study. Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM, ESLD-HIV Working Group Investigators. Liver Transpl; 2009 Sep 31; 15(9):1133-41. PubMed ID: 19718643 [Abstract] [Full Text] [Related]
14. Postprandial hypotension predicts all-cause mortality in older, low-level care residents. Fisher AA, Davis MW, Srikusalanukul W, Budge MM. J Am Geriatr Soc; 2005 Aug 31; 53(8):1313-20. PubMed ID: 16078956 [Abstract] [Full Text] [Related]
15. A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study. Joly P, Roujeau JC, Benichou J, Delaporte E, D'Incan M, Dreno B, Bedane C, Sparsa A, Gorin I, Picard C, Tancrede-Bohin E, Sassolas B, Lok C, Guillaume JC, Doutre MS, Richard MA, Caux F, Prost C, Plantin P, Chosidow O, Pauwels C, Maillard H, Saiag P, Descamps V, Chevrant-Breton J, Dereure O, Hellot MF, Esteve E, Bernard P. J Invest Dermatol; 2009 Jul 31; 129(7):1681-7. PubMed ID: 19177141 [Abstract] [Full Text] [Related]